ESTRO37_ProgrammeBook

> Results of proton therapy for castration resistant prostate cancer M. Takagi (Japan), Y. Demizu, N. Fuwa, K. Terashima, O. Fujii, D. Jin, Y. Niwa, M. Hareyama, T. Okimoto > Impact of reduced PTV margins on toxicity in prostate carcinoma treated with image guided IMRT S.S. Nanda (India), M. Rastogi, A. Gandhi, R. Khurana, K. Sahni, R. Hadi, S.P. Mishra, A. Srivastava, S. Farzana, M.L.B. Bhatt > Salvage SBRT for local recurrence of prostate cancer after definitive radiotherapy D. Lam Cham Kee (France), J. Doyen, A. Falk, J.M. Hannoun-levi > Is Neoadjuvant ADT Necessary for Intermediate-Risk Prostate Cancer Treated with Proton Therapy? M. Takagi (Japan), Y. Demizu, N. Fuwa, N.S. Sulaiman, K. Terashima, O. Fujii, D. Jin, F. Nagano, T. Waki, M. Mima, Y. Niwa, K. Katsui, M. Murakami, T. Okimoto > Effect of patient positioning on organs at risk in postoperative radiotherapy for prostate cancer S. Sawayanagi (Japan), H. Yamashita, M. Ogita, W. Takahashi, K. Nakagawa > Long term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapy J. De Leon (Australia), A. Kneebone, V. Gebski, S. Cross, V. Do, A. Hayden, D. Ngo, M. Sidhom, S. Turner > Salvage nodal RT for PSMA avid oligomets in hormone naive prostate cancer patients: GCC Experience T.S. Lim (Australia), J. Dortmans, S. Sia, R. Chee > Radiotherapy for T3b prostate cancer (with seminal involvement): clinical analyses F. Goupy (France), E. Le Prisé, D. Williaume, C. Lafond, A. Simon, N. Perichon, C. Hervé, B. Leproust, R. De Crevoisier > Clinical Outcomes of 3D CRT with HDR brachytherapy in patients with localized Prostate cancer M. Rafi (Pakistan)

EP-1568

ELECTRONIC POSTERS

EP-1569

EP-1570

EP-1571

EP-1572

EP-1573

EP-1574

EP-1575

EP-1576

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

298